Abstract:Ribosomally-synthesized and post-translationally-modified peptides (RiPPs) are a major class of natural products. It originates from a corresponding biosynthetic gene cluster where the genes for a precursor peptide and several post-translational modification (PTM) enzymes are located. The precursor peptide is translated by a ribosome, recognized on the N-terminal leader peptide and modified on the C-terminal core peptide by PTM enzymes, to finally give a structurally unique mature compound. So far, the RiPPs found by researchers only account for a small part of the family, and there are a large number of compounds remaining to be discovered. The S-adenosylmethionine radical (rSAM) enzyme family is one of the largest enzyme superfamilies, containing more than 22000 members. These enzymes are widely distributed in eukarya, bacteria and archaea and are considered to be one the earliest biocatalysts on earth which perform essential and inseparable functions in cells. As more substantial microbial genomic information becomes available, a large number of RiPPs are excavated as natural products by high-throughput analyses. Genome mining in microorganisms reveals great abundance of biosynthetic gene clusters consisting of co-occurring rSAM enzyme and RiPPs' peptide genes, mostly leading to complex bioactive compounds whether reported or not. Recently, three genera, Xenorhabdus, Yersinia, and Erwinia, are unified with the definition of XYE system, for they all employ a highly conserved rSAM enzyme responsible for modifying its adjacent peptide to create a distinctive C-C or C-O bond in the final RiPPs product. Yet complex compounds synthesized through the rSAM enzyme modifying a precursor peptide in the XYE system have rarely been reported. Through algorithm analysis, we monitored a biosynthetic gene cluster in the Xenorhabdus sp. KJ12.1 comforming a similar construction of that in an XYE system. We fully synthesized the precursor peptide and the rSAM enzyme genes from Xenorhabdus sp. KJ12.1, heterologously expressed the modifying system in Escherichia coli and successfully obtained a novel ribopeptide Xenopeptide. Structure analysis showed that the rSAM enzyme XenB is involved in the formation of two C-C bonds on the side groups of the precursor, one between tryptophan14(W14) and asparagine16 (N16), the other between tryptophan21(W21) and lysine23(K23). Although bioactivity tests proved the compound without a confirmed antimicrobial activity, we can still expect the utilization of the product elsewhere with its chemical complexity. These results indicate a developmental potential of combining computer technology and biological engineering. Our work provides a fundamentally theoretical basis for in-depth genome mining and a practically technical flow for finding modified compounds in microorganisms. The combination of genetic manipulation, biosynthetic characterization and structure determination is expected to further decipher the mechanistic enzymology involved in C-C crosslink formation. This strategy will shed light on the structure-activity relationships involved in the maturation of this subclade of RiPPs. Moreover, thorough biosynthetic engineering of Xenopeptide's precursor peptide and relevant enzymes through rational design and directed mutation will facilitate the development of a variety of Xenopeptide analogs with enhanced bioactivities. This paper will not only disclose the enzymatic underpinnings underlying the biosynthesis of C-C crosslinks, but also point out new directions for structural derivatization of bioactive peptides.

Production of marine-derived bioactive peptide molecules for industrial applications: A reverse engineering approach

Bioactive Peptides from Marine Organisms

Advances in Biosynthesis of Natural Products from Marine Microorganisms

Exploring Newer Biosynthetic Gene Clusters in Marine Microbial Prospecting

Challenges and advances in genome mining of ribosomally synthesized and post-translationally modified peptides (RiPPs)

Microbial production of small peptide: pathway engineering and synthetic biology

Emerging Trends of Biotechnology in Marine Bioprospecting: A New Vision

Next-generation synthetic biology approaches for the accelerated discovery of microbial natural products

Engineering the biosynthesis of fungal nonribosomal peptides

Chemical Strategies for Visualizing and Analyzing Endogenous Nonribosomal Peptide Synthetase (NRPS) Megasynthetases

Genome mining strategies for ribosomally synthesised and post-translationally modified peptides

Synthetic Biology Strategy to Discover a Novel Ribosomal Peptide, Xenopeptide

Recent Advances in the Heterologous Expression of Biosynthetic Gene Clusters for Marine Natural Products

Discovery and Engineering of Ribosomally Synthesized and Post-Translationally Modified Peptide (ripp) Natural Products

Embracing the era of antimicrobial peptides with marine organisms

Membrane-active peptides from marine organisms--antimicrobials, cell-penetrating peptides and peptide toxins: applications and prospects

Mining and Biosynthesis of Bioactive Lanthipeptides from Microorganisms.

Can be marine bioactive peptides (MBAs) lead the future of foodomics for human health?

Engineering Biosynthesis of Non-ribosomal Peptides and Polyketides by Directed Evolution

Bioprospecting marine microalgae as sustainable bio-factories for value-added compounds